$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞格列克片的副作用与注意事项
2025-10-19 11:44:20
Check Details
瑞格列克片的用药指南
2025-10-19 11:44:20
Check Details
瑞格列克片的适应症
2025-10-19 11:44:20
Check Details
鲁卡帕尼(rucaparib)获FDA批准作为单药治疗BRCA1/2突变的转移性去势抵抗性前列腺癌(mCRPC)患者
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的用法用量:常用剂量、剂量调整
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的详细说明书:适应症、用法用量、副作用及注意事项等
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的副作用如何缓解
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)是治疗什么疾病的
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的注意事项和药物相互作用
2025-10-19 11:44:20
Check Details
卢卡帕利(rucaparib)的购买渠道
2025-10-19 11:44:20
Check Details
瑞戈非尼治疗难治性转移性结直肠癌建议采用剂量递增策略
2025-10-19 11:44:20
Check Details
结直肠癌的检查项目有哪些?
2025-10-19 11:44:20
Check Details
1
2
...
1587
1588
1589
1590
1591
1592
1593
...
4157
4158
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Osimertinib Safety Guide: Foods to Avoid, Mechanism of Action, and Pre-Treatment Warnings
2
Tivozanib: A Next-Generation Highly Selective VEGFR-Targeted Therapy Explained
3
Capmatinib Clinical Guide: Drug Comparisons, Treatment Strategies, and Combination Therapy Prospects
4
Pralsetinib Clinical Guide: Discontinuation Principles, Drug Comparisons, and Treatment Strategies
5
Dabrafenib Clinical Guide: Indications, Combination Strategies, and BRAF Inhibitor Comparisons
6
Cabozantinib Capsules: A Multi-Targeted Therapy for Progressive Medullary Thyroid Cancer
7
Lorlatinib: Mechanism, Advantages, and Key Considerations of Third-Generation ALK Inhibitor Therapy in ALK-Positive NSCLC
8
Pemigatinib Side Effects Explained: Managing Adverse Reactions of FGFR-Targeted Therapy in Cholangiocarcinoma
9
Selpercatinib: Before or After Meals? A Complete Guide to RET-Targeted Therapy Administration
10
Mitotane for Adrenocortical Carcinoma: Dosing Guidelines and Therapeutic Drug Monitoring
11
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
12
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)